Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keli Li

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Vaccine|February 4, 2018
Recipient vaccine-associated paralytic poliomyelitis in China, 2010-2015Wendi Wu, Huaqing Wang, Keli Li, et al.
Respirology (Carlton, Vic.)|June 15, 2022
Effectiveness of influenza and pneumococcal vaccines on chronic obstructive pulmonary disease exacerbationsYan Li, Pingshu Zhang, Zhijie An, et al.
Vaccine|July 5, 2020
Two media-reported vaccine events in China from 2013 to 2016: Impact on confidence and vaccine utilizationWenzhou Yu, Lingsheng Cao, Yanmin Liu, et al.
Vaccine|March 13, 2026
Post-marketing surveillance of adverse events following enterovirus type 71 inactivated vaccine in China, 2016-2023Keli Li, Yan Li, Lina Zhang, et al.
Human Vaccines & Immunotherapeutics|May 13, 2021
Immunogenicity of trivalent seasonal influenza vaccine in patients with chronic obstructive pulmonary diseaseYan Li, Ying Ma, Zhijie An, et al.
China CDC Weekly|October 1, 2021
Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine in Patients with Chronic Obstructive Pulmonary Disease - Hebei Province, China, September-December, 2019Yan Li, Ying Ma, Zhijie An, et al.
China CDC Weekly|December 29, 2025
Technical and Implementation Guidelines for the Introduction of Human Papillomavirus Vaccine into China's National Immunization ProgramFuzhen Wang, Lei Cao, Keli Li, et al.
The Lancet Regional Health. Western Pacific|December 9, 2021
Immunogenicity and safety of inactivated enterovirus A71 vaccines in children aged 6-35 months in China: a non-inferiority, randomised controlled trialYan Li, Fan Gao, Yamin Wang, et al.
JMIR Public Health and Surveillance|June 17, 2025
Minimum Data Set and Metadata for Active Vaccine Safety Surveillance: Systematic ReviewMengdi Zhang, Junting Yang, Yan Li, et al.
International Journal of Epidemiology|May 14, 2016
Loss of confidence in vaccines following media reports of infant deaths after hepatitis B vaccination in ChinaWenzhou Yu, Dawei Liu, Jingshan Zheng, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Vaccine|February 4, 2018
Recipient vaccine-associated paralytic poliomyelitis in China, 2010-2015Wendi Wu, Huaqing Wang, Keli Li, et al.
Respirology (Carlton, Vic.)|June 15, 2022
Effectiveness of influenza and pneumococcal vaccines on chronic obstructive pulmonary disease exacerbationsYan Li, Pingshu Zhang, Zhijie An, et al.
Vaccine|July 5, 2020
Two media-reported vaccine events in China from 2013 to 2016: Impact on confidence and vaccine utilizationWenzhou Yu, Lingsheng Cao, Yanmin Liu, et al.
Vaccine|March 13, 2026
Post-marketing surveillance of adverse events following enterovirus type 71 inactivated vaccine in China, 2016-2023Keli Li, Yan Li, Lina Zhang, et al.
Human Vaccines & Immunotherapeutics|May 13, 2021
Immunogenicity of trivalent seasonal influenza vaccine in patients with chronic obstructive pulmonary diseaseYan Li, Ying Ma, Zhijie An, et al.
China CDC Weekly|October 1, 2021
Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine in Patients with Chronic Obstructive Pulmonary Disease - Hebei Province, China, September-December, 2019Yan Li, Ying Ma, Zhijie An, et al.
China CDC Weekly|December 29, 2025
Technical and Implementation Guidelines for the Introduction of Human Papillomavirus Vaccine into China's National Immunization ProgramFuzhen Wang, Lei Cao, Keli Li, et al.
The Lancet Regional Health. Western Pacific|December 9, 2021
Immunogenicity and safety of inactivated enterovirus A71 vaccines in children aged 6-35 months in China: a non-inferiority, randomised controlled trialYan Li, Fan Gao, Yamin Wang, et al.
JMIR Public Health and Surveillance|June 17, 2025
Minimum Data Set and Metadata for Active Vaccine Safety Surveillance: Systematic ReviewMengdi Zhang, Junting Yang, Yan Li, et al.
International Journal of Epidemiology|May 14, 2016
Loss of confidence in vaccines following media reports of infant deaths after hepatitis B vaccination in ChinaWenzhou Yu, Dawei Liu, Jingshan Zheng, et al.
Pageof 4